Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Atai Life Sciences AG

ATAI is a biotechnology company founded in 2018 in response to the clear and growing unmet needs of mental health patients worldwide. ATAI is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. ATAI's business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential. By pooling resources and best practices, ATAI aims to responsibly accelerate the development of new medicines across its business entities, seeking to effectively treat and ultimately heal mental health disorders. ATAI's mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. ATAI is headquartered in Berlin, with offices in New York and San Diego. *


Period Start 2018-07-05 established
Products Industry LIFE SCIENCES
  Industry 2 venture capital
Persons Person Brand, Florian (ATAI Life Sciences 202004 CEO)
  Person 2 Angermayer, Christian (Apeiron Investment 202010 Founder formerly Co-founder of Ribopharma)
Region Region München (Munich)
  Country Germany
  Street 7 Barer Str.
  City 80333 München
  Tel +49-89-2153-9035
    Address record changed: 2021-03-05
Basic data Employees n. a.
    * Document for �About Section�: Atai Life Sciences AG. (11/23/20). "Press Release: Atai Life Sciences Announces Closing of $125 Million Series C Financing Round". New York, NY.
Record changed: 2021-04-16


Picture [iito] Made Without Love 650x80px

More documents for Atai Life Sciences AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top